Abeona therapeutics regains compliance with nasdaq listing requirements

New york and cleveland, july 20, 2022 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo) today announced that it received notice from the nasdaq stock market llc (nasdaq) on july 19, 2022 informing abeona that it has regained compliance with the minimum bid price requirement under nasdaq listing rule 5550(a)(2) (the “rule”) for continued listing on the nasdaq capital market. in order to regain compliance with the rule, the company's common stock was required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive trading days. that requirement was met on july 18, 2022.
ABEO Ratings Summary
ABEO Quant Ranking